Should AFP (or any biomarkers) be used for HCC surveillance?

@article{Mohammed2017ShouldA,
  title={Should AFP (or any biomarkers) be used for HCC surveillance?},
  author={Hager F Ahmed Mohammed and Lewis R. Roberts},
  journal={Current hepatology reports},
  year={2017},
  volume={16 2},
  pages={137-145}
}
A PURPOSE OF REVIEW To address the controversy around the use of biomarkers for hepatocellular carcinoma (HCC) surveillance in individuals with cirrhosis or chronic hepatitis B who are at risk for development of liver cancer. B RECENT FINDINGS Recent studies suggest that surveillance for hepatocellular carcinoma is beneficial, even after adjustment for… CONTINUE READING